1-9 of 9
Rimke Oostvogels
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR

Moniek de Witte, Jojanneke Scheepstra, Naomi Weertman, Annet Daudeij, Lotte van der Wagen, Rimke Oostvogels, Colin de Haar, Henk-Jan Prins, Willem Dohmen, Carly Bartels-Wilmer, Inez Johanna, Zsolt Sebestyen, Jurgen Kuball, Trudy Straetemans
Journal: Blood
Blood (2022) 140 (Supplement 1): 12737–12739.
https://doi.org/10.1182/blood-2022-158191
Published: 2022
Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Fleur A De Groot, Jeanette K. Doorduijn, Mirian Brink, Ruben A.L. De Groen, Lorraine M. De Haan, Troy Noordenbos, Aniko Sijs-Szabo, King Hong Lam, Arjan Diepstra, Liane te Boome, Valeska Terpstra, Lara H. Böhmer, Josée M. Zijlstra, Lianne Koens, Marc Durian, Mirjam A. Oudshoorn, Hendrik Veelken, Marjolein W.M. Van Der Poel, Myrurgia Abdul Hamid, Wendy B.C. Stevens, J L.M van Rooij, Rimke Oostvogels, Karen J. Neelis, Michiel van den Brand, F.J. Sherida H. Woei-a-Jin, Thomas Tousseyn, Daan Dierickx, Patty M. Jansen, Marie Jose Kersten, Jacoline Bromberg, Marcel Nijland, Joost S.P. Vermaat
Journal: Blood
Blood (2022) 140 (Supplement 1): 369–371.
https://doi.org/10.1182/blood-2022-163244
Published: 2022
Journal Articles

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Clinical Trials & Observations
Mirian Brink, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G. N. J. Mutsaers, Lara H. Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Wouter Plattel, Gerwin A. Huls, Joost S. P. Vermaat, Marcel Nijland
Journal: Blood
Blood (2022) 140 (9): 1009–1019.
https://doi.org/10.1182/blood.2021015114
Published: 2022
Includes: Supplemental data
Journal Articles

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Frederik O. Meeuwes, Mirian Brink, Marjolein W.M. Van Der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G.N.J. Mutsaers, Lara H. Böhmer, F.J. Sherida H. Woei-a-Jin, Otto J. Visser, Rimke Oostvogels, Patty M. Jansen, Karen J. Neelis, Anne P.G. Crijns, Laurien A. Daniëls, Joost S.P. Vermaat, Gerwin A. Huls, Marcel Nijland
Journal: Blood
Blood (2021) 138 (Supplement 1): 1381.
https://doi.org/10.1182/blood-2021-148038
Published: 2021
Journal Articles

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Clinical Trials & Observations
Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee Yong, Vania Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksac, Katja Weisel, Kenneth C. Anderson, María-Victoria Mateos, Philippe Moreau, Jesus San-Miguel, Nikhil C. Munshi, Hervé Avet-Loiseau
Journal: Blood
Blood (2020) 136 (26): 3033–3040.
https://doi.org/10.1182/blood.2020008150
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Clinical Trials & Observations
Inger S. Nijhof, Laurens E. Franssen, Mark-David Levin, Gerard M. J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Paula F. Ypma, Reinier Raymakers, Dick-Johan van Spronsen, Peter E. Westerweel, Rimke Oostvogels, Jeroen van Velzen, Berris van Kessel, Tuna Mutis, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Niels W. C. J. van de Donk
Journal: Blood
Blood (2016) 128 (19): 2297–2306.
https://doi.org/10.1182/blood-2016-07-729236
Published: 2016
Includes: Supplemental data
Journal Articles

Identification of Minor Histocompatibility Antigens Based on the 1000 Genomes Project for Application in Therapeutic Dendritic Cell Vaccination

Rimke Oostvogels, MD, Henk M. Lokhorst, MDPhD, Maureen van Elk, Kelly van den Oudenalder, Eric Spierings, PhD, Monique C. Minnema, MDPhD, Tuna Mutis, MDPhD, Robbert Spaapen, PhD
Journal: Blood
Blood (2014) 124 (21): 2418.
https://doi.org/10.1182/blood.V124.21.2418.2418
Published: 2014
Journal Articles

Improved Vaccine Design For Adoptive Immunotherapy In Hematological Malignancies Through Chemically Modified Minor Histocompatibility Antigen Epitopes

Rimke Oostvogels, MD, Rieuwert Hoppes, Henk Lokhorst, Robbert M Spaapen, PhD, Huib Ovaa, PhD, Tuna Mutis, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5435.
https://doi.org/10.1182/blood.V122.21.5435.5435
Published: 2013
Journal Articles

Identification of New Hematopoietic Minor Histocompatibility Antigen UTA2-1; Ready for Application in Antitumor Immunotherapy

Rimke Oostvogels, MD, Monique C. Minnema, MD PhD, Maureen van Elk, Robbert M Spaapen, PhD, Debbie van Baarle, PhD, Eric Spierings, PhD, Henk M. Lokhorst, MD, Tuna Mutis, MD PhD
Journal: Blood
Blood (2011) 118 (21): 2979.
https://doi.org/10.1182/blood.V118.21.2979.2979
Published: 2011